Publicaciones > Artículos en revista JCR

2021

1

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

Zarzuelo Romero MJ, Pérez Ramírez C, Carrasco Campos MI, Sánchez Martín A, Calleja Hernández MA, Ramírez Tortosa MC, Jiménez Morales A.

Journal of Personalized Medicine; 2021,

Indicio de calidad: 15/108 (Medine General & Internal). 4.945

1

Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis

Márquez Pete N , María Del Maldonado Montoro MM , Pérez Ramírez C , Fernando Martínez Martínez F , Juan Enrique Martínez de la Plata JE, Daddaoua A, Jiménez Morales A

Journal of Personalized Medicine . 2021 Jun 18;11(6):573. doi: 10.3390/jpm11060573.

Indicio de calidad: 24/165 (Medine General & Internal). 4945

1

Influence of Genetic Polymorphisms on Clinical Outcomes of GlatiramerAcetate in Multiple Sclerosis Patients

Zarzuelo Romero MJ, Pérez Ramírez C, Cura Y, Carrasco Campos MI, Marangoni LM, Ramírez Tortosa MC, Jiménez Morales A.

Journal of Personalized Medicine

Indicio de calidad: 15/108 (Health Care Sciences & Services). 4945

1

Adaptation of practical classes of clinical subjects in the COVID-19 era

Zarzuelo MJ, Valverde-Merino MI, Sanchez-Perez de Lara L, Martinez-Martinez F

Brazilian Journal of Pharmaceutical Sciences

Indicio de calidad: 251/275 (Pharmacology & Pharmacy). 1.321

1

Intervention model for detection, prevention and control of COVID-19 in community pharmacy

Cortes-Fernandez E, Zarzuelo MJ, Valverde-Merino MI, Martinez-Martinez F

Brazilian Journal of Pharmaceutical Sciences

Indicio de calidad: 251/275 (Pharmacology & Pharmacy). 1.321

1

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer

Pineda Lancheros, L, Pérez Ramírez C, Sánchez Martín A, Gálvez Navas JM, Martínez Martínez F, Ramírez Tortosa MC, Jiménez Morales A.

Nutrients 2021. 13, no. 11: 3783. https://doi.org/10.3390/nu13113783

Indicio de calidad: 17/88 (Nutrition & Dietetics). 5.719

1

Cost–Utility Analysis of a Medication Adherence Management Service Alongside a Cluster Randomized Control Trial in Community

Valverde-Merino MI, Martinez-Martinez F, Garcia-Mochon L, Benrimoj SI, Malet-Larrea A, Perez-Escamilla B, Zarzuelo MJ, Torres-Robles A, Gastelurrutia MA, Varas-Doval R, Peiro Zorrilla T, Garcia-Cardenas V.

Patient Prefer Adherence. 2021;15:2363-2376. https://doi.org/10.2147/PPA.S330371

Indicio de calidad: 63/167 (Medine General & Internal). 2.711, T2, Q2

1

Hospitalization budget impact during the COVID-19 pandemic in Spain

Carrera-Hueso FJ, Álvarez-Arroyo L , Poquet-Jornet JE , Vázquez-Ferreiro P , Martínez-Gonzalbez R, El-Qutob D, Ramón-Barrios MA, Martínez-Martínez F, Poveda-Andrés JL and Crespo-Palomo C

Health Economics Review (2021) 11:43 https://doi.org/10.1186/s13561-021-00340-0

Indicio de calidad: 210/557 (Economics). FI: 2.306

2

Impact of a risk-sharing agreement in rheumatoid arthritis in Spain.

García-Collado CG, Martínez-de-la-Plata JE, Montoro MDMM, Morales AJ, Hernández MÁC, Martínez FM

Health Policy . 2021 Mar;125(3):335-340. doi: 10.1016/j.healthpol.2020.11.009. Epub 2020 Nov 16.

Indicio de calidad: 33/87 (Health Care Sciences & Services). 2.212

3

Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies.

Varas-Doval R, Saéz-Benito L, Gastelurrutia M. A, Benrimoj S. I, Garcia-Cardenas V, and Martinez-Martínez F.

BMC Health Services Research (2021) 21:156

Indicio de calidad: 57/102 (Health Policy & Services). 1.987

4

Results Of Development And Application Of An Objective Structured Clinical Examination: A Pioneering Experience In Pharmaceutical Care.

Zarzuelo MJ, Valverde-Merino MI, Fernandez-Rodriguez M, Amador-Fernandez N, Uribe-Sanchez A, Gomez-Guzman M, Martinez-Martinez F.

Indian Journal Of Pharmaceutical Education And Research. 2021.

Indicio de calidad: 266/275 (Pharmacology & Pharmacy). 0.686

5

Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis

Cancela Díez B, Pérez-Ramírez C, Maldonado-Montoro MDM, Carrasco-Campos MI, Sánchez Martín A, Pineda Lancheros LE, Martínez-Martínez F, Calleja-Hernández MÁ, Ramírez-Tortosa MC, Jiménez-Morales A.

Pharmacogenet Genomics. 1;31(2):40-47. doi: 10.1097/FPC.0000000000000420.

Indicio de calidad: 116/271 (Pharmacology & Pharmacy). 2.940

6

Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis

Membrive Jiménez C, Pérez Ramírez C, Sánchez Martín A, Vieira Maroun S, Arias Santiago SA, Ramírez Tortosa MDC, Jiménez Morales A.

J Pers Med. 2021 Apr 12;11(4):293. doi: 10.3390/jpm11040293. PMID: 33921427 Free PMC article. Review.

Indicio de calidad: 10/102 (Health Care Sciences & Services). 4.433

7

Multimodal Interventions to Improve the Management of Chronic Non-Malignant Pain in Primary Care Using Participatory Research

Morcillo-Muñoz Y, Holgado Jiménez Castellano, Díaz Exposito FJ, Sanchez-Guarnido AJ, Gimenez Alcantara M, Baena-Parejo MI

Clinics and Practice. Aug 26;11(3):561-581. doi: 10.3390/clinpract11030072.

Indicio de calidad: 181/315 (Medicine, General & Internal). 0.23

8

Validation of a spanish version of the ‘Unité Rhumatologique Des Affections De La Main’ (URAM) scale

Gómez-Herrero D, Carrera-Hueso FJ , Sanjuan-Cerveró R , Montaner-Alonso D , Aguilella-Fernandez L , Vazquez-Ferreiro P , Poquet-Jornet JE, García-Jiménez E

Journal of Plastic Reconstructive and Aesthetic Surgery . 2021 Jul;74(7):1621-1628. doi: 10.1016/j.bjps.2020.11.024. Epub 2020 Dec 5.

Indicio de calidad: 90/212 (Surgery). 2.740

2020

1

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Efectiveness of Abatacept in Patients with Rheumatoid Arthritis

Marquez Pete N, Maldonado Montoro MM, Pérez Ramírez C, Sánchez Martín A, Martínez de la Plata JE, Martínez Martínez F, Caliz Caliz R, Daddaoua A, Ramírez Tortosa MC, Jiménez Morales A

J Pers Med . 2020 Nov 11;10(4):220. doi: 10.3390/jpm10040220.

Indicio de calidad: 24/165 (Medine General & Internal). 4.433

1

Validation of a spanish versión of the “Unité Rhumatologiqué de Affections de la Main” (URAM) scale.

Gómez-Herrero D, Carrera-Hueso FJ, Sanjuán-Cerveró R, Montaner-Alonso D, Aguilella-Fernández L, Vazquez-Ferreiro P, Poquet-Jornet JE, García-Jiménez E.

Journal of Plastic, Reconstructive & Aesthetic Surgery

Indicio de calidad: 72/210 (Surgery). 2.390

2

Collaborative health service planning: a stakeholder analysis with social network analysis to develop a community pharmacy service

Franco-Trigo L, Marqués-Sánchez P, Tudball J, Benrimoj SI, Martínez-Martínez F, Sabater-Hernández D.

Res Social Adm Pharm. 2020 Feb;16(2):216-229. doi: 10.1016/j.sapharm.2019.05.008. Epub 2019 May 21.

Indicio de calidad: 33/171 (Public, Environmental & Occupational Health). 2.844

3

Using network analysis to explore factors moderating the implementation of a medication review service in community pharmacy.

Pérez-Escamillla B, Benrimoj SI, Martínez-Martínez F, Gastelurrutia MÁ, Varas-Doval R, Musial-Gabrys K, Garcia-Cardenas V.

Res Social Adm Pharm . 2020 Dec 19;S1551-7411(20)31212-2. doi: 10.1016/j.sapharm.2020.12.007. Online ahead of print.

Indicio de calidad: 33/71 (Public, Environmental & Occupational Health). 2.844

4

Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta

Martínez-Aguilar L, Pérez-Ramírez C, Maldonado-Montoro MDM, Carrasco-Campos MI, Membrive-Jiménez C, Martínez-Martínez F, García-Collado C, Calleja-Hernández MÁ, Ramírez-Tortosa MC, Jiménez-Morales A

Mutat Res/Reviews in Mutation Research. Jul-Sep 2020;785:108322. doi: 10.1016/j.mrrev.2020.108322. Epub 2020 Jul 7.

Indicio de calidad: 20/178 (Genetic Heredity). 5.803

5

Evaluating an implementation programme for medication review with follow-up in community pharmacy using a hybrid effectiveness study design: translating evidence into practice.

Varas-Doval R, Gastelurrutia MA , Benrimoj SI, Zarzuelo MJ, Garcia-Cardenas V, Perez-Escamilla B, Martinez-Martinez F.

BMJ Open . 2020 Sep 29;10(9):e036669. doi: 10.1136/bmjopen-2019-036669.

Indicio de calidad: 52/165 (Medine General & Internal). 2.496

6

Association of genetic polymorphisms on methotrexate toxicity in patients with rheumatoid arthritis.

Zarzuelo Romero MJ, Martínez Martínez F, Maldonado Montoro MM, Pérez Ramírez C, Calleja Hernández MA, Márquez Pete N, Sánchez Martín A, Jiménez Morales A, Ramírez Tortosa MC.

Archives of Medical Science. 2020.

Indicio de calidad: 51/169 (Medine General & Internal). 3.318

7

Stakeholder analysis in health innovation planning processes: Asystematic scoping review

Franco-Trigo l, Fernandez-Llimos F, Martínez-Martínez F, Benrimoja SI, Sabater-Hernández D

Health Policy . 2020 Oct;124(10):1083-1099. doi: 10.1016/j.healthpol.2020.06.012. Epub 2020 Jun 30.

Indicio de calidad: 33/87 (Health Care Sciences & Services). 2.212

8

Training in Professional Pharmacy Services through Educational Videos.

Zarzuelo Maria Jose, Valverde-Merino Maria-Isabel, Fernandez-Rodriguez Maria, Amador-Fernandez Noelia, Martinez-Martinez Fernando.

Indian Journal of Pharmaceutical Education and Research, 2020.

Indicio de calidad: 266/275 (Pharmacology & Pharmacy). 0.686

9

Questionnaires on adherence to antihypertensive treatment: a systematic review of published questionnaires and their psychometric properties

Pareja-Martínez E, Esquivel-Prados E, Martínez- Martínez F, García-Corpas JP

Int J Clin Pharm . 2020 Apr;42(2):355-365. doi: 10.1007/s11096-020-00981-x. Epub 2020 Feb 5.

Indicio de calidad: 228/271 (Pharmacology and Pharmacy). 1.616

11

Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program.

Sadyrbaeva-Dolgova S, Aznarte-Padial P, Jimenez-Morales A, Expósito-Ruiz M, Calleja-Hernández MÁ, Hidalgo-Tenorio C.

J Infect Public Health. 2020 Apr;13(4):558-563. doi: 10.1016/j.jiph.2019.09.014. Epub 2019 Nov 1. PMID: 31685404 Free article.

Indicio de calidad: 73/193 (Public, Environmental & Occupational Health). 2.447

12

Acute coronary syndrome and recurrent colitis as immune-related adverse events in a lung cancer patient.

Cancela-Díez B, Gómez-De Rueda F, Antolinos Pérez MJ, Jiménez-Morales A, López-Hidalgo JL.

J Oncol Pharm Pract. 2020 Jan;26(1):252-255. doi: 10.1177/1078155219865596. Epub 2019 Aug 5. PMID: 31382863

Indicio de calidad: 213/244 (Oncology). 1.850

2019

1

A stakeholder visioning exercise to enhance chronic care and the integration of community pharmacy services.

Franco-Trigo L, Tudball J, Fam D, Benrimoj SI, Sabater-Hernández D.

Res Social Adm Pharm, 2019, Jan;15(1):31-44. doi: 10.1016/j.sapharm.2018.02.007. Epub 2018 Feb 21

Indicio de calidad: 37/157 (Public, Enviromental, Ocupacional Health). 2.322

2

Hydroxytyrosol, antioxidant of extra virgin olive oil, modifies the levels of TIMP-1 in plasma of women with breast cancer.

Ramirez-Tortosa C, Sanchez A, Perez-Ramirez C, Quiles JL, Robles-Almazan M, Pulido-Moran M, Sanchez-Rovira M, Ramirez-Tortosa MC

Antioxidants, 2019, En prensa

Indicio de calidad: 63/298 (Biochemestry & Molecular Biology). 4.520

3

FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis

Jiménez Morales A, Maldonado-Montoro M, Martínez de la Plata JE, Pérez Ramírez C, Daddaoua A, Alarcón Payer C, Expósito Ruiz M, García Collado C.

J Clin Pharmacol. 2019 Apr;59(4):517-531. doi: 10.1002/jcph.1341. Epub 2018 Nov 20.

Indicio de calidad: 110/267 (Pharmacology and Pharmacy). 2.915

5

A comparative analysis of the pharmacovigilance systems of Brazil, Spain, the European Union and the United States based on the information provided by their regulatory agency websites.

Leal MM, Sanz MM, Ferrando JRC, Martinez-Martinez F.

Daru, 2019, Feb 18. doi: 10.1007/s40199-019-00249-4

Indicio de calidad: 118/261 (Pharmacology & Pharmacy). 2.667

6

Cross sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 Study.

Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez Martínez F et al.

BMJ Open, 2019, 9:e028467. doi:10.1136/ bmjopen-2018-02846

Indicio de calidad: 50/160 (Medicine, General & Internal). 2.376

7

A Global Comparison of Internationalization Support Characteristics Available on College of Pharmacy Websites.

Nunes-da-Cunha I, Martinez Martinez F, Fernandez-Llimos F.

American Journal of Pharmaceutical Education, 2019, 83 (3) Article 6592

Indicio de calidad: 22/41 (Education, Scientific Disciplines). 1.495

8

Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model.

Nogueras A, Chinchilla Fernández MI, Martínez F, Faus MJ, Martínez Sesmero JM, Poveda Andrés JL, Calleja MÁ

Eur J Hosp Pharm Sci Pract, 2019, Jul; 26(4):242-243. doi: 10.1136/ejhpharm-2019-001905. Epub 2019 Jul 4

Indicio de calidad: 251/267 (Pharmacology & Pharmacy). 0.717

2018

1

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenomics Journal, 2018, doi 10.1038/s41397-018-0014-8

Indicio de calidad: 50/261 (Pharmacology & Pharmacy). 3.812

2

Methodological quality assessment of network meta-analysis of drug interventions: implications from a systematic review.

Tonin FS, Borba HH, Leonart LP, Mendes AM, Steimbach LM, Pontarolo R, Fernandez-Llimos F.

Int J Epidemiol, 201,8 Sep 12. doi: 10.1093/ije/dyy197. [Epub ahead of print]

Indicio de calidad: 5/181 (Public, Enviromental, Ocupacional Health). 8.360

3

Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Metabolic Syndrome and Endothelial Functional Risk Biomarkers in Healthy Adults: A Randomized Double-Blind Controlled Trial.

Sanchez-Rodriguez E, Lima-Cabello E, Biel-Glesson S, Fernandez-Navarro JR, Calleja MA, Roca M, Espejo-Calvo JA, Gil-Extremera B, Soria-Florido M, de la Torre R, Fito M, Covas MI, Alche JD, Martinez de Victoria E, Gil A, Mesa MD.

Nutrients, 2018, May 16; 10(5). pii: E626. doi: 10.3390/nu10050626

Indicio de calidad: 18/83 (Nutrition & Dietetics). 4.196

4

Comparison of interventions to improve long-term medication adherence across different clinical conditions: a systematic review with network meta-analysis.

Torres-Robles AJ, Wiecek E, Tonin FS, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V.

Frontiers in Pharmacology, 2018, 24;9:1454

Indicio de calidad: 48/261 (Pharmacology & Pharmacy). 3.831

5

An innovative and comprehensive technique to evaluate different measuresof medication adherence: The network meta-analysis.

Tonin FS, Wiecek E, Torres-Robles A, Pontarolo R, Benrimoj SI, Fernandez-Llimos F, & Garcia-Cardenas V.

Research in Social & Administrative Pharmacy, 2018, pii: S1551-7411(18)30407-8

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

6

A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.

Hossain LN, Tudball J, Franco-Trigo L, Durks D, Benrimoj SI, & Sabater-Hernández, D.

Research in Social & Administrative Pharmacy, 2018, 14(8):765-775

Indicio de calidad: 37/157 (Pharmacology & Pharmacy). 2.322

7

A review of international pharmacy-based minor ailment services and proposed service design model.

Aly M, Garcia-Cardenas V, Williams KA, Benrimoj, SI.

Research in Social & Administrative Pharmacy, 2018, 14 (11):989-998

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

8

A qualitative study of stakeholder views and experiences of minor aliment services in the United Kingdom

Aly M, García-Cárdenas V, Williams KA, Benrimoj SI.

Research in Social & Administrative Pharmacy, 2018, pii: S1551-7411(18)30221-3

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

10

Burnout en el personal de un Hospital de Crónicos.

Merino-Plaza MJ, Carrera-Hueso FJ, Arribas-Boscá N, Martínez-Asensi A, Trull-Mararavilla E, Fikri-Benbrahim N.

Revista Saude Publica, 2018, https://doi.org/10.11606/S1518-8787.2018052000242

Indicio de calidad: 120/176 (Public health, environmental & occupational health). 1.353

11

Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observacional longitudinal studies.

Leonart LP, Tonin FS, Ferreira VL, Fernandez-Llimos F, Pontarolo R.

Endocrine, 2018, https://doiorg/10.1007/s12020-018-1729-7.

Indicio de calidad: 63/174 (Endocrinology & Metabolism). 3.179

12

Defining a set of standar dised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.

Blade J, Calleja MÁ, Lahuerta JJ, Poveda JL, de Paz HD, Lizán L.

BMJ Open, 2018, Feb 22; 8(2):e018850. doi: 10.1136/bmjopen-2017-018850

Indicio de calidad: 43/155 (Medicine, General & Internal). 2.413

13

Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with in flammatory bowel disease.

Guerra Veloz MF, Argüelles-Arias F, Castro Laria L, Maldonado Pérez B, Benítez Roldan A, Perea Amarillo R, Merino Bohórquez V, Calleja MA, Caunedo Álvarez Á, Vilches Arenas Á.

World J Gastroenterol, 2018, Dec 14; 24(46):5288-5296

Indicio de calidad: 35/80 (Gastroenterology & Hepatology). 3.300

14

Economic impact of medication non-adherence by disease groups: a systematic review.

Cutler, R. L.,Fernandez-Llimos, F., Frommer, M., Benrimoj, S. I.& Garcia-Cardenas, V.

BMJ open, 2018, Jan 21;8(1):e016982.doi:10.1016/j.sapharm.2017.12.004

Indicio de calidad: 50/160 (Medicine, General & Internal). 2.376

15

A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation.

Sabater-Hernández D, Tudball J, Ferguson C, Franco-Trigo L, Hossain LN, Benrimoj SI.

BMC Health Serv Res, 2018, Feb 27; 18(1):145.

Indicio de calidad: 53/94 (Health Care Sciences & Services). 1.843

16

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Delgado JR, Calleja-Hernández MA, Faus-Dáder MJ

Pathology Res Practice, 2018, 214: 44-52

Indicio de calidad: 55/79 (Pathology). 1.466

17

Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH.

Garrido P, Aldaz A, Vera R, Calleja MA, de Álava E, Martín M, Matías-Guiu X, Palacios J.

Clin Transl Oncol, 2018, Apr; 20(4):443-447. doi: 10.1007/s12094-017-1740-0. Epub 2017 Aug 31

Indicio de calidad: 156/223 (Oncology). 2.392

18

A model for the financial assessment of professional services in community pharmacy: a systematic review.

Zeater S, Benrimoj, SI, Fernandez-Llimos F, & Garcia-Cardenas V.

Journal of the American Pharmacists Association, 2018, [Epub ahead of print]doi: 10.1016/j.japh.2018.04.029

Indicio de calidad: 223/261 (Pharmacology & Pharmacy). 1.315

19

Pharmacists in general practice: a focus on drug‑related problems.

Benson H, Lucas C, Kmet W, Benrimoj SI, & Williams KA.

International Journal of Clinical Pharmacy, 2018, Jun;40(3):566-572.

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). 1.508

20

Characterization of pharmacists’ interventions on asthma management: a systematic review.

Crespo-Gonzalez C. Fernandez-Llimos F, Rotta I, Correr CJ, Benrimoj SI, & Garcia-Cardenas V.

Journal of the American Pharmacists Association, 2018, Mar - Apr;58(2):210-219

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). 1.508

2017

1

Intraocular lens dislocation in pseudo exfoliation: a systematic review and meta-analysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey M, Ramon Barrios MA.

Acta Ophthalmol, 2017; 95(3): e164-169

Indicio de calidad: 12/59 (Opthalmology). 3.324

2

Patients’ expectations of the role of the community pharmacist: Development and testing of a conceptual model.

Sabater-Galindo M, Ruiz de Maya S, Benrimoj SI, Gastelurrutia Garralda MA, Martínez-Martínez F, & Sabater-Hernández D.

Research in Social & Administrative Pharmacy, 2017, 13(2), 313-320.

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

3

Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients.

Malet-Larrea A, Goyenechea E, Gastelurrutia MA, Calvo B, García-Cárdenas V, Cabases JM, Noain A, Martínez-Martínez F, Sabater-Hernández D, Benrimoj SI.

Eur J Health Econ, 2017, Dec; 18(9):1069-1078

Indicio de calidad: 51/353 (Economics). 2.601

5

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

Pérez-Ramírez C, Cañadas-Garre M, Molina-Vila MA, Robles AI, Faus-Dáder MJ, Calleja-Hernández MA.

Mutation Res Reviews in Mutation Res, 2017, 771: 32-58

Indicio de calidad: 26/171 (Genetic & Hereditary). 5.205

6

The complexity of implementation factors in professional pharmacy services.

Garcia-Cardenas V, Pérez-Escamilla B, Fernandez-Llimos F, & Benrimoj SI.

Research in Social & Administrative Pharmacy , 2017, May 29. pii: S1551-7411(17)30501-6.doi: 10.1016/j.sapharm.2017.05.016

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

7

Testing evidence routine practice: Using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy.

Fuller JM, Saini, B, Bosnic-Anticevich, S, Garcia-Cardenas V, Benrimoj SI, & Armour C.

Research in Social & Administrative Pharmacy, 2017,13(5), 989-996

Indicio de calidad: 37/157 (Public Health, Environmental & Occupational Health). 2.322

8

The next phase in professional services research: From implementation to sustainability.

Crespo-Gonzalez C, Garcia-Cardenas V, & Benrimoj SI.

Research in Social & Administrative Pharmacy, 2017, 13(5), 896-901

Indicio de calidad: 37/157 (Public, Enviromental, Ocupacional Health). 2.322

9

Evaluation of the implementation process and outcomes of a professional pharmacy service in community pharmacy setting. A case report.

Garcia-Cardenas V, Benrimoj SI, Castrillon Ocampo C, Goyenechea E, Martinez-Martinez F, & Gastelurrutia Garralda MA.

Research in Social & Administrative Pharmacy, 2017, 13(3), 614-627.

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

10

Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.

Franco-Trigo L, Hossain LN, Durks D, Fam D, Inglis S., Benrimoj SI, & Sabater-Hernández D.

Research in Social & Administrative Pharmacy, 2017, 13(3), 539-552

Indicio de calidad: 37/157 (Public, Environmental & Occupational Health). 2.322

11

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Molina MA, Robles AI, Villar E, Delgado JR, Faus-Dáder MJ, Calleja-Hernández MA.

Surg Oncol, 2017, 26(3): 278-285

Indicio de calidad: 60/200 (Surgery). 2.558

12

Cytokine single-nucleotide polymorphisms and risk of non-small cell lung cancer.

Pérez-Ramírez C, Alnatsha A, Cañadas-Garre M, Villar E, Valdivia-Bautista J, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenet Genomics, 2017; 27(12): 438-444.

Indicio de calidad: 117/261 (Biotecnology & Applied Microbiology). 2.250

13

Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners.

Hossain LN, Fernandez-Llimos F, Luckett T, Moullin JC, Durks D, Franco-Trigo L, Benrimoj SI, Sabater-Hernández D.

BMJ Open, 2017, Sep 5;7(9):e015471

Indicio de calidad: 43/154 (Medicine, General & Internal). 2.413

14

Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review.

Durks D, Fernandez-Llimos F, Hossain LN, Franco-Trigo L, Benrimoj SI, Sabater-Hernández D.

Health Educ Behav, 2017, Aug; 44(4):524-535

Indicio de calidad: 55/156 (Public Health, Environmental & Occupational Health). 1.899

15

Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders.

Alañón Pardo MM, Ferrit Martín M, Calleja Hernández MA, Morillas Márquez F.

Eur J Clin Pharmacol, 2017, 73: 1305-1313

Indicio de calidad: 117/261 (Pharmacology & Pharmacy). 2.679

16

Medication adherence and persistence in type diabetes mellitus: perspectives of patiens, physicians and pharmacists on the Spanish heal care system.

Labrador-Barba E, Rodríguez de Miguel M, Hernández-Mijares A, Alonso-Moreno FJ, Orera-Peña ML, Aceituno S, Faus-Dáder MJ.

Patiens Preference and Adherence, 2017; 11:707-718

Indicio de calidad: 70/155 (Medicine, General & Internal). 1.733

17

Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.

Sanjuan-Cerveró R, Carrera-Hueso FJ, Vazquez-Ferreiro P, Fikri-Benbrahim N, Franco-Ferrando N, Peimer CA.

Journal of Hand Surgery, 2017, 42(2):109-114

Indicio de calidad: 40/77 (Ortopedics). 1.776

18

Relación entre la satisfacción laboral y la cultura de seguridad del paciente.

Merino-Plaza MJ, Carrera-Hueso FJ, Roca-Castelló MR, Morro-Martín MD, Martínez-Asensi A, Fikri-Benbrahim N.

Gac Sanit, 2017, doi: 10.1016/j.gaceta.2017.02.009

Indicio de calidad: 108/181 (Public Health, Environmental & Occupational Health). 1,581

19

Modelling elderly patients’ perception of the community pharmacist image when providing professional services.

Sabater-Galindo M, Sabater-Hernández D, Ruiz de Maya S, Gastelurrutia Garralda MA, Martínez-Martínez F, & Benrimoj SI.

Health and Medicine, 2017, 22(5), 578-587.

Indicio de calidad: 107/181 (Public, Environmental & Occupational Health). 1.589

20

Impact of a program me for patients with chronic disease initiated at the emergency department on drug-related negative outcomes: a randomised controlled trial.

Juanes A, Garín N, Mangues MA, Herrera S, Puig M, Faus MJ, Baena MI.

Eur J Hosp Pharm, 2017, 1-7.

Indicio de calidad: 250/261 (Pharmacology & Pharmacy). 0.538

21

Costan alysisfor the implementation of a medication review with follow-up service in Spain.

Noain A, Garcia-Cardenas V, Gastelurrutia MA, Malet-Larrea A, Martinez-Martinez F, Sabater-Hernandez D, Benrimoj SI.

Int J Clin Pharm, 2017, Aug; 39(4):750-758

Indicio de calidad: 209/261 (Pharmacology & Pharmacy). 1.508

22

Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.

Ríos-Tamayo R, Martín-García A, Alarcón-Payer C, Sánchez-Rodríguez D, de la Guardia AMDVD, García Collado CG, Jiménez Morales A, Jurado Chacón M, Cabeza Barrera J.

Drug Des Devel Ther.

Indicio de calidad: 99/271 (Pharmacology and Pharmacy). 3.216

23

Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service.

Puig L, Notario J, Jiménez-Morales A, Moreno-Ramírez D, López-Ferrer A, Gozalbo I, Prades M, Lizán L, Blanch C.

J Dermatolog Treat. 2017 Nov;28(7):623-630. doi: 10.1080/09546634.2017.1364687. Epub 2017 Oct 5. PMID: 28784002

Indicio de calidad: 25/64 (Dermatology). 2.144

2016

1

Model for the evaluation of implementation programs and professional pharmacy services.

Moullin JC, Sabater-Hernández D, Benrimoj SI.

Res Social Adm Pharm, 2016, May-Jun; 12(3): 515-22.

2.403

3

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Maldonado-Montoro M, Cañadas-Garre M, González-Utrilla A, Plaza-Plaza JC, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Jun 20; 111: 264-271.

4.816

4

ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Segura-Pérez AM, Chamorro-Santos C, Vergara-Alcaide E, Castillo-Portellano L, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Apr 30;108: 111-118.

4.816

5

Intraocular lens dislocation in pseudoexfoliation: a systematic review and meta-analysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey M, Ramón-Barrios MA.

Acta Ophthalmol, 2016, 1-6.

3.032

6

The impact of a Medication Review with Follow-up service on hospital admissions in aged polypharmacy patients.

Malet-Larrea A, Goyenechea E, García-Cárdenas V, Calvo B, Arteche JM, Aranegui P, Zubeldia JJ, Gastelurrutia MA, Martínez-Martínez F, Benrimoj SI.

Br J Clin Pharmacol, 2016, May 14. doi: 10.1111/bcp.13012.

3.830

7

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.

Pérez-Ramírez C, Cañadas-Garre M, Alnatsha A, Villar E, Delgado JR, Calleja-Hernández MA, Faus-Dáder MJ.

Pharmacol Res, 2016, Aug 3; 111:877-884.

4.816

8

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Maldonado-Montoro M, Cañadas-Garre M, González-Utrilla A, Plaza-Plaza JC, Calleja-Hernández MÁ.

Pharmacol Res, 2016, Sep;111: 264-271.

4.816

9

A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular diseases.

Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, Franco-Trigo L, Lones LA, Correr CJ, Benrimoj SI.

J Manag Care Spec Pharm, 2016, 22 (6): 699-713.

2.713

10

Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective.

Sabater-Galindo M, Fernández-Llimós F, Sabater-Hernández D, Martínez-Martínez F, Benrimoj SI.

Patient Educ Couns, 2016, Mar; 99(3):339-347.

2.199

11

Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting.

Garcia-Cardenas V, Benrimoj SI, Ocampo CC, Goyenechea E, Martinez-Martinez F, Gastelurrutia MA.

Research in Social & Administrative Pharmacy, 2016, doi:10.1016/j.sapharm.2016.05.048.

1.860

12

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.

Galindo J, Amariles P, Mueses-Marín HF, Hincapié JA, González-Avendaño S, Galindo-Orrego X

BMC Infect Dis, 2016, Oct 3;16(1): 532.

2.690

13

Free software to analyse the clinical relevance of drug interactions with antiretroviral agents (SIMARVR) in patients with HIV/AIDS.

Giraldo NA, Amariles P, Monsalve M, Faus MJ.

Res Social Adm Pharm. 2016. [23 Sep 2016, 13(4):831-839]

1.936

14

Safe implementation of standard concentration infusions in paediatric intensive care.

Safe implementation of standard conceArenas-López S, Stanley IM, Tunstell P, Aguado-Lorenzo V, Philip J, Perkins J, Durward A, Calleja-Hernández MA, Tibby SM.

J Pharm Pharmacol, 2016, Jun 23 doi: 10.1111/jphp.12580.

2.363

15

Patients’ Perspective of Medication Adherence in Chronic Conditions: A Qualitative Study.

Pagès-Puigdemont N, Mangues MA,Masip M, Gabriele G, Fernández-Maldonado L, Blancafort S, Tuneu L.

Adv Ther , 2016, 33:1740-1754.

2.503

16

AIntraoperative complications of phacoemulsification in pseudoexfoliation: Metaanalysis.

Vazquez-Ferreiro P, Carrera-Hueso FJ, PoquetJornet JE, Fikri-Benbrahim N, Barreiro-Rodriguez L, Diaz-Rey, M, Ramon Barrios M.

J Cataract Refract Surg, 2016; 42:1666-1675.

2.687

17

Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach.

Sabater-Hernández D, Moullin J, Hossain L, Durks D, Franco-Trigo L, Fernandez-Llimos F, Martínez Martínez, Saez-Benito L, De la Sierra A, Benrimoj SI.

Am J Health Syst Pharm, 201,. 73:156-164.

1.882

18

Prevalence and predictors of inadequate patient medication knowledge.

Romero-Sanchez J, Garcia-Cardenas V, Abaurre R, Martínez-Martínez F, Garcia-Delgado P.

J Eval Clin Pract, 2016, Oct; 22(5): 808-815.

1.053

19

Qualitative study on the implementation of professional pharmacy services in community pharmacy using framework analysis.

Moullin JM, Sabater-Hernández D, Benrimoj SI.

BMC Health Serv Res, 2016, 16: 439. FI: 1.606. Q3

1.606

20

Development and testing of two implementation tools to measure components of professional pharmacy service fidelity.

Moullin JM, Sabater-Hernández D, Garcia-Corpas JP, Kenny P, Benrimoj SI.

J Eval Clin Pract, 2016, 22(3): 369-377.

1.053

21

Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies.

Amariles P, Pino-Marín D, Sabater-Hernández D, García-Jiménez E, Roig-Sánchez I, Faus MJ.

Aten Primaria, 2016, Nov; 48(9):586-595.

1.098

22

Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy.

Domingues EA, Ferrit Martin M, Calleja Hernandez MA.

Int J Clin Pharm, 2016, DOI 10.1007/s11096-016-0387-1.

1.339

23

Cardiovascular risk in HIV patients aged 50 years and over on antiretroviral therapy: an observational follow-up study.

Domingues EA, Ferrit-Martín M, Calleja-Hernández MA.

Lat Am J Pharm, 2016, 35(Suppl. 1):1083-91

0.329

24

Liquid biopsy in ear lystage lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Transl Lung Cancer Res, 2016, Oct; 5(5): 517–524.

4.806

2015

1

Pharmacists’ interventions on clinical asthma outcomes: a systematic review.

García-Cárdenas V, Armour C, Benrimoj SI, Martínez-Martínez F, Rotta I, Fernández-Llimós.

Eur Respir J, 2015 ,Apr; 47 (4): 1134-43. doi: 10.1183/13993003.01497-2015.

8.332

2

Ensayo clínico controlado y aleatorizado para evaluar el efecto que tiene la intervención de un farmacéutico especialista en los problemas relacionados con la medicación de pacientes ancianos ingresados en una unidad de corta estancia de urgencias.

Piqueras Romero C, Calderón Hernanz B, Segura Fragoso A, Juárez González R, Berrocal Javato MA, Calleja Hernández MA.

Emergencias, 2015, 27: 364-370.

2.895

3

Differences in cancer drug assessment between Spain and the United Kingdom.

Lozano-Blázquez A, Rickson R, Fraga-Fuentes MD, Martínez-Martínez F, Calleja-Hernández MÁ.

Eur J Cancer, 2015, Sep; 51(13):1843-52.

5.417

4

MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacol Research, 2015, 102: 90-106. FI: 4.408. Q1

4.408

5

Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.

Cortés de Miguel S, Calleja-Hernández MÁ, Menjón-Beltrán S, Vallejo-Rodríguez I.

Support Care Cancer, 2015, Feb; 23(2): 547-59.

2.535

6

Trends in survival of multiple myeloma: a thirty-year population-based study in a single institution.

Ríos-Tamayo R, Sánchez MJ, Puerta JM, Sáinz J, Chang DY, Rodríguez T, López P, de Pablos JM, Navarro P, de Veas JL, Romero A, Garrido P, Moratalla L, Alarcón-Payer C, López-Fernández E, González PA, Jiménez-Moleón JJ, Calleja-Hernández MÁ, Jurado M.

Cancer Epidemiol, 2015, Oct;39(5):693-9.

2.644

7

The effect on potential adverse drug events of a pharmacist-acquired medication history in an emergency department: a multicentre, double-blind, randomised, controlled, parallel-group study.

Becerra-Camargo J, Martínez-Martínez F, García-Jiménez E.

BCM Health Services Research, 2015 15:337. DOI 10.1186/s12913-015-0990-1.

1.712

8

Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE Program.

Jódar F, Malet A, Martín JJ, García, L, López del Amo MP, Martínez-Martínez F, Gastelurrutia MA, García-Cárdenas V, Sabater-Hernández, Sáez-Benito L, Benrimoj B.

Pharmacoeconomics, 2015, Jun;33(6): 599-610.

2.450

9

A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework.

Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI.

Health Res Policy Syst, 2015, 13(16): 1-11.

1.810

10

Pharmaceutical care in smoking cessation.

Marín Armero A, Calleja MA, Perez-Vicente S, Martinez Martinez F.

Patient Preference and Adherence 2015; 9: 209-2015.

1.676

11

PTEN and PI3K/AKT in non small cell lung cancer.

Pérez-Ramírez C, Cañadas-Garre M, Robles AI, Molina MA, Faus-Dáder MJ, Calleja-Hernández MA.

Pharmacogenomics, 2015, 16(6): 1843-1862.

3.218

12

MET: A New Promising Biomarker in Non-Small Cell Lung Carcinoma.

Pérez-Ramírez C, Cañadas-Garre M, Jiménez-Varo E, Faus-Dáder MJ, Calleja Hernández MA.

Pharmacogenomics, 2015, Apr; 16(6): 631-47.

3.218

13

Extrapolation of acenocoumarol pharmacogenetic algorithms.

Jiménez-Varo E, Cañadas-Garre M, Garcés-Robles V, Gutiérrez-Pimentel MJ, Calleja-Hernández MÁ.

Vascul Pharmacol, 2015, Nov;74:151-7.

2.500

14

Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ.

Breast Cancer Res Treat, 2015, Oct;153(3): 493-505.

4.085

15

De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.

Madrid-Paredes A, Cañadas-Garre M, Sánchez-Pozo A, Calleja-Hernández MÁ.

Pharmacogenomics, 2015, 16(12):1411-26.

3.218

16

Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments.

Pérez-Escamilla, B., Franco-Trigo, L., Moullin, J.C., Martínez-Martínez, F., García-Corpas, J.P.

Patient Prefer Adherence, 2015, 13; 9 569–578.

1.676

17

Medication List Assessment in Spanish Hospital Emergency Departments.

Medication List AssBaena Parejo MI, Juanes Borrego AM, Altimiras Ruiz J, Crespí Monjó M, García-Peláez M, Calderón Hernanz B, Calleja Hernández MÁ, Chinchilla Fernández MI, Prats Riera M, García Sánchez R, García Sánchez L, Vázquez López C, Mauleon Echeverria MD, Mas Serrano P. J

Emerg Med, 2015, Apr;48(4):416-23.

0.969

18

Diseño y pilotaje de un proceso estructurado para el servicio de dispensación de medicamentos.

Abaurre R, García-Delgado P, Maurandi MD, Arrebola C, Gastelurrutia MA, Martínez-Martínez F.

Aten Primaria, 2015, 17(1): 7 – 14.

0.953

19

Pharmacist perception of the use of analgesics and their practice on mild-moderate pain. DOLOR-OFF survey

Arrebola C, García-Delgado P, Labrador Barba E, Orera Peña ML, Martínez-Martínez F.

Aten Primaria, 2015, Oct 28.

0.953

20

Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes.

Castrillón Ocampo c, Garcia-Cardenas V, Martinez-Martinez F, Benrimoj SI, Amariles P, Gastelurrutia MA.

Int J Clin Pharm, 2015 Oct;37(5):931-40.

1.348

21

Caracterization of patients´ requests and pharmacists´ professional practice in oropharyngeal condition in Spain.

Hernández A, García-Delgado P, García-Cardenas V, Ocaña A, Labrador E, Orera ML.

Int J Clin Pharm, 2015, 37(2): 300-9.

1.348

22

Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study. [Original].

Fikri-Benbrahim N, Martinez-Martinez F, Sáez-Benito L, Luque BS, Corpas JP, Moullin JC et al.

Diabetes Research and Clinical Practice, 2015, 108(3): 49-52.

2.538

23

Prevalence and detection of neuropsychiatric adverse effects during hepatitis C treatment.

Masip M, Tuneu L, Pagès N, Torras X, Gallego A, Guardiola JM, Faus MJ, Mangues MA.

Int J Clin Pharm, 2015, Dec; 37 (6): 1143-51Epud 2015. DOI 10.1007/s11096-015-0177-1.

1.348

24

Development and testing of two implementation tools to measure components of professional pharmacy service fidelity.

Moullin JC, Sabater-Hernández, García-Corpas JP, Kenny P, Benrimoj SI.

J Eval Clin Pract, 2015, Dec 29.doi: 10.1111/jep.12496.

1.084

25

Negative outcomes associated with medication in patients with chronic atrial fibrillation who present at the emergency department.

Torres-Degayón V, Torres-Murillo JM, Baena-Parejo MI, Muñoz-Villanueva MC, Montes- Redondo G, Calleja-Hernández MA, Faus-Dáder MJ.

Journal of Clinical Pharmacy and Therapeutics, 2015, 40: 452-60.

1.668

26

Usefulness of blood pressure measurements by community pharmacists in screening for hypertension the screenBpharm study: a protocol.

Marín-Rives FR, Sendra-Lillo J, Morales F, Sabater-Hernández D.

Lat Am J Pharm, 2015, 34(2): 237-243.

0.372

27

Adherence to Antihypertensive Therapy in Community Pharmacy: Evaluating the Psychometric Properties of the Morisky Medication Adherence Scale (MMAS-8) Translated into Spanish. Pilot Study.

Pareja-Martínez E, Esquivel-Prados E, Franco-Trigo L, García-Corpas JP.

Lat Am J Pham. 2014; 33(5):739-45.

0.319

28

Identifying masked uncontrolled hypertension in the community pharmacy setting.

Sabater-Hernández D, Sendra-Lillo J, Jiménez-Monleón JJ, Benrimoj S, Durks D, Martínez-Martínez F, de la Sierra A.

Blood Press Monit, 2015, 20(3): 138-43.

1.531

29

Validity of home blood pressure measurements manually registered by patients after an educational session provided by community pharmacists.

Sendra-Lillo J, Martínez-Martínez , García-Corpas JP, Marín Rivas F, Sabater-Hernández D.

Blood Press Monit, 2015, 20(4):232-6.

1.531

30

Atención Farmacéutica en el Fomento del Desayuno Saludable desde la Oficina de Farmacia.

Marín Rives F, Morales Marin F, Marín Rives LV, Gastelurrutia Garralda MA.

Nutr Hosp, 2015, 32 (03): 1267-1272.

1.497

31

Use of pemetrexed for non-small celllung cancer in theAndalusian public health system.

Pérez-Moreno MA, Cotrina-Luque J, Galván-Banqueri M, Flores-Moreno S, Bautista-Paloma FJ, Calleja-Hernández MÁ.

J Chemother, 2015, 27(6): 371-7.

1.333

2014

1

Pharmacogenetics role in the safety of acenocoumarol therapy.

Jiménez-Varo E, Cañadas-Garre M, Henriques CI, Pinheiro AM, Gutiérrez-Pimentel MJ, Calleja-Hernández MA.

Thromb Haemost, 2014, Sep 2;112(3):522-36.

4.984

2

Implementing smart pump technology in a pediatric intensive care unit: a cost-effective approach.

Manrique-Rodríguez S, Sánchez-Galindo AC, López-Herce J, Calleja-Hernández MA, Martínez Martínez F, Iglesias- Peinado I, Carrillo-Álvarez A, Sanjurjo-Sáez M, Fernández-Llamazares CM.

Int J Med Inform, 2014, Feb;83(2): 99-105.

2.004

3

Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).

Losada-Camacho M, Guerrero-Pabón MF, García-Delgado P y Martínez-Martínez F.

Health Qual Life Outcomes, 2014, Oct 31; 12(1):162.

2.120

4

The effect of an educational intervention to improve patient antibiotic adherence during dispensing in a community pharmacy.

Bernabé E, Martínez F, Espejo J, Flores M.

Aten Primaria, 2014, 46(7): 367-375.

0.953

5

Comparación de las intervenciones de educación sanitaria y de seguimiento farmacoterapéutico en pacientes con factores de riesgo cardiovascular que acuden a una farmacia comunitaria (Estudio FISFTES-PM).

Bofí Martínez P, García-Jiménez E.

Aten Primaria, 2014, http://dx.doi.org/10.1016/j.aprim.2014.04.012.

0.953

6

Characterization of patients’ requests and pharmacists’ professional practice concerning the oropharyngeal condition in Spain.

Hernández A, García-Delgado P, García-Cárdenas V, Ocaña A, Labrador E, Orera ML, Martínez-Martínez F.

International Journal of clinical pharmacy, 2015, 37; 2: 300-309.

1.348

7

Grado de conocimiento del antibiótico prescrito en pacientes ambulatorios.

Bernabé Muñoz E, Flores Dorado M, Martínez-Martínez F.

Aten Primaria, 2014, DOI: 10.1016/J.APRIM.2014.04.014.

0.953

8

Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.

Lozano-Blázquez A, Calvo-Pita C, Carbajales-Álvarez M, Suárez-Gil P, Martínez-Martínez F, Calleja-Hernández MA.

Therapeutics and Clinical Risk Management, 2014, 10: 527–535.

1.469

9

Effectiveness of the Dader Method for pharmaceutical care in patients with bipolar I disorder: EMDADER-TAB: study protocol for a randomized controlled trial.

Salazar-Ospina A, Amariles P, Benjumea DM, Gutierrez F, Faus MJ, Rodriguez LF.

Trials, 2014, May 20;15:174. doi: 10.1186/1745-6215-15-174.

1.731

10

Lifestyles habits and sleeps quality in patients over age of 65 attending community pharmacies.

García-Corpas JP, Sabater-Hernández D, Martínez-Martínez F.

Lat Am J Pham, 2014, 33(5):739-45.

0.319

11

Validación del cuestionario de medida del conocimiento del paciente sobre su medicamento adaptado al portugués.

Salmerón-Rubio J, García-Delgado P, Iglésias-Ferreira P, Mateus-Santos H, Martínez-Martínez F.

Ciência & Saúde Coletiva, 2014, 19(4): 1141-1150. 18(12):3633-3644.

0.56

2013

1

Negative clinical outcomes of medication resulting in emergency department visits.

Baena MI, Fajardo PC, Pintor-Marmol A, Faus MJ, Marin R, Zarzuelo A.et al.

Eur J Clin Pharmacol, 2013, 70(1): 79-87.

2.697

2

Effect of a pharmacist intervention on asthma control. A cluster randomised trial.

García-Cárdenas V, Sabater-Hernández D, Kenny P, Martínez-Martínez F, Faus MJ, Benrimoj SI.

Respir Med, 2013, Sep;107(9): 1346-55.

2.917

3

Comparison of drug survival rates for tumor necrosis factor antagonists in reumatoide artritis.

Martínez-Santana V, González-Sarmiento E, Calleja-Hernández M, Sánchez-Sánchez T.

Patient Prefer Adherente, 2013, Jul 29; 7:719-27.

1.330

4

Evidence of the clinical effectiveness of cognitive pharmaceutical services for aged patients.

Sáez-Benito L, Fernandez-Llimos F, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Benrimoj SI.

Age Ageing, 2013, 42(4): 442-449.

3.107

5

Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.

Salgado TM, Arguello B, Martinez-Martinez F, Benrimoj SI, Fernandez-LlimosF.

Eur J Clin Pharmacol, 2013, 69(11): 1973-9.

2.697

6

Relationship between urinary albumin excretion and blood pressure in the community pharmacy. The Palmera study.

Sendra-Lillo J, Sabater-Hernández D, de la Sierra A, Sendra-Ortolá A, Denia-Tomás A, Martínez-Martínez F.

Am J Hypertens, 2013, 26(1): 3-4.

3.402

7

A multicentre, double-blind, randomised, controlled, parallel-group study of the effectiveness of a pharmacist-acquired medication history in an emergency department.

Becerra Camargo JB, Martinez F, García-Jiménez E.

BMC Health Serv Res, 2013, Aug 29; 13(1): 337.

1.659

8

Drug-related visits to the emergency department in Spanish university hospital.

Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA.

Drug-related visits to the emergency department in Spanish university hospital. Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA. Int J Clin Pharm. 2013; 35: 727-735.

1.250

9

Impact of a community pharmacists’ hypertension-care service on medication adherence. The AFenPA Study.

Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, Sabater-Hernández D.

Res Social Adm Pharm, 2013, 9(6): 797-805.

1.375

10

Revisión de la medicación de pacientes polimedicados en atención primaria.

Flores M, Baena MI, Jiménez J, Tormo J, Faus MJ, Martínez F.

Aten Primaria, 2013, 45(4): 222-3.

0.894

11

Reply to the paper: Defining professional pharmacy services in community pharmacy.

Gastelurrutia MA, Faus MJ, Martínez-Martínez F.

Research in Social and Administrative Pharmacy, 2013, DOI: 10.1016/j.sapharm.2013.05.005

1.375

12

Priorización de facilitadores para la implantación del seguimiento farmacoterapéutico en las farmacias comunitarias españolas mediante la aplicación de análisis factorial exploratorio.

Gil MI, Benrimoj SI, Martínez-Martínez F, Cardero M, Gastelurrutia MA.

Aten Primaria, 2013, 45(7): 368-375.

0.894

13

Impact of implementing smart infusion pumps in a pediatric intensive care unit.

Manrique-Rodríguez S, Sánchez-Galindo A, López-Herce J, Calleja-Hernández MA, Martínez-Martínez F, Iglesias-Peinado I, Carrillo-Álvarez Á, Sanjurjo-Sáez M, Fernández-Llamazares CM.

Am J Health Syst Pharm, 2013, 70 (21): 1897-906.

2.205

14

Programa conSIGUE Impacto. Evaluación del impacto clínico, económico y humanístico del seguimiento farmacoterapéutico en adultos mayores polimedicados.

Martínez-Martínez F, García-Cárdenas V, Sáez-Benito L, Varas R, Gastelurrutia MA, Sabater-Hernández D, Faus MJ, Benrimoj SI.

Vitae, 2013, 20 (supl. 1): S15-S18.

0.259

15

Effectiveness and safety of doxorubicinloadedbeads in hepatocellular carcinoma.

Muros-Ortega M, Díaz-Carrasco MS, Capel A, Calleja MÁ, Martínez F.

Int J ClinPharm, 2013, 35(6): 1105-12.

1.250

16

Prevalencia y Factores asociados al insomnio y mala calidad de sueño en pacientes con VIH/SIDA en Sevilla, España.

García-Corpas JP, Monje-Agudo P, Labriola C, Morillo-Verdugo R.

Vitae, 2013, 20(3): 195-202.

0.259

17

Diseño de un paciente virtual para el entrenamiento y práctica de la Atención Farmacéutica.

Martínez-Martínez F, García-Cárdenas V, Fikri-Benbrahim N, García-Delgado P, Faus MJ.

Vitae, 2013, (Supl 1): S52-S53.

0.325

18

Prevalence and Attitude Towards Smoking in First, Third and Fifth-year Pharmacy Students in Spain: PRECOTABAC Study.

Muñoz Muñoz E, García-Jiménez E, Martínez-Martínez F, Espejo Guerrero J.

Therapie, 2013, 68(6): 375-383.

0.397

19

Effectiveness of Pharmacotherapy Follow-Up for the Control of Hypertensive Patients in Community Pharmacies: EMDADER-HTA Study.

Rodríguez-Chamorro A, García-Jiménez E, Rodríguez-Chamorro MA, Amariles P, Martínez-Martínez F, Pérez-Merino E, González-García l, Faus-Dader MJ.

Latin Am J Pharm, 2013, 32 (7): 982-988.

0.319

20

Effect of Pharmacotherapy Follow-Up on Treatment Adherence and Virologic and Immune Response in Patients with Human Immunodeficiency Virus.

Romero Jiménez R, Calleja Hernández MA, Chaparro Recio M, Martínez-Martínez F, Sanjurjo Sáez M.

Latin American Journal of Pharmacy, 2013, 32 (3): 441-447.

0.319

21

Análisis de la dispensación de antibióticos en pacientes ambulatorios.

Bernabé Muñoz E, Flores Dorado M, Martinez-Martinez F.

Vitae, 2013, 20 (3): 2013-2014.

0.259

22

Adaptação intercultural para português europeu do questionário “Conocimiento del Paciente sobre sus Medicamentos” (CPM-ES-ES).

Salmerón-Rubio J, Iglésias-Ferreira P, García-Delgado P, Mateus-Santos H, Martínez-Martínez F.

Ciência & Saúde Coletiva, 2013, 18(12):3633-3644.

0,56

2012

1

Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.

Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ.

J Manage Care Pharm. May; 18(4):311-23.

2.414

2

The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation

Calleja MA, Vieites JM, Montero-Meterdez T, Torres MI, Faus MJ, Gil MA, Suárez A.

British Journal of Nutrition. 2012: 1-18.

3.302

3

Impact of clinical pharmacist interventions in reducing paediatric prescribing errors.

Fernández-Llamazares C, Calleja MA, Manrique-Rodriguez S, Pérez- Sánz C, Durán-García E, Sanjurjo-Saéz M.

Arch Dis Child. 2012; 97: 564–568.

3.051

4

Usefulness of Blood Pressure Measurement by Community Pharmacists in the Management of Hypertension.

Sabater-Hernández D, Sendra-Lillo J, Faus MJ, Martínez-Martínez F, de la Sierra A.

Journal of Managed Care Pharmacy. July/August 2012; 18: (6): 453-456.

2.414

5

Agreement between community pharmacy, physician’s office and home blood pressure measurement methods. The PALMERA study.

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá A, Martínez-Martínez F.

Am J Hypertens. 2012; 25 (3): 290-296.

3.665

6

Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain. European Journal of Clinical Pharmacology.

Fernández-Llamazares C, Calleja MA, Manrique-Rodriguez S , Pérez- Sánz C, Durán-García E, Sanjurjo-Saéz M.

Eur J Clin Pharmacol 2012; 68(9):1339-45.

2.741

7

Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.

Plaza-Plaza JC, Aguilera M, Cañadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA.

OMICS A Journal of Integrative Biology. 2012; 16(11): 589-595.

FI: 2.730. Q2

8

Terms used in patient safety related to medication: a literature review.

Pintor-Mármol A, Baena MI, Fajardo PC, Sabater-Hernández D, Sáez-Benito L, García-Cárdenas MV, Fikri-Benbrahim N, Azpilicueta I, Faus MJ.

Pharmaco epidemiol Drug Saf. 2012; 21(8): 799-809.

FI: 2,897. Q2

9

Effectiveness of off-label use of bevacizumab in recurrent ovarian and metastatic breast cancer.

Araque Arroyo P, Cuesta Santos P, Ferrit M, Cancela B, Alañón AM, Valenzuela JC, Calleja MA.

Aten Farm 2012; 14(3): 167-73.

FI: 0.125. Q3

10

Medication reconciliation: passing phase or real need?

Durán E, Fernández-Llamazares CM, Calleja M.

International Journal of Clinical Pharmacy 2012; 34(6): 797-802.

FI: 1.250. Q3

11

Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure controlin hypertensive patients. The AFenPA study.

Fikri-Benbrahim N, Faus MJ, Martínez-Martínez F, González-Segura Alsina D, Sabater-Hernández D.

Am J Health-Syst Pharm. 2012; 69: 1311-1318.

FI: 1.984. Q3

12

Errors in turbuhaler technique in a spanish population of asthmatic patients.

García-Cárdenas V, Sabater-Hernández D, García-Corpas JP, Faus MJ, Martínez-Martínez F, Benrimoj SI.

Respir Care. 2012; 57(5): 817-8.

FI: 2.030. Q3

13

Is the inhaler technique associated with asthma control?Letter to the editor.

García-Cárdenas V, Sabater-Hernández D, Faus MJ, Martínez Martínez F, Benrimoj SI.

Journal of Asthma, 2012: 42(2): 170-171.

FI: 1.848. Q3

14

Resultados Negativos asociados a la Medicación que son causa de visita al Servicio de Urgencias de un Centro de Atención Primaria.

Martínez Jiménez V, Flores Dorado M, Jiménez Vicente P, Martínez Martínez F.

Aten Primaria 2012; 44(3): 128-135,

FI: 0.957. Q3

15

Severe pancy to penia following etanercept administration in rheumatoid arthritis.

Martínez Santana V, Izquierdo Navarro M, Calleja Hernández MA, Sánchez Sánchez T, Sainz Gil, M.

International Journal of Rheumatic Diseases 2012; 15(4): e78–e79.

1.469

16

MEPAFAR Study Workgroup. Agreement between community pharmacy and ambulatory and blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.

Sabater-Hernández D, De La Sierra A, Sánchez-Villegas P, Santana-Pérez FM, Merino-Barber L, Faus MJ.

J Clin Hypertens. 2012; 14(4): 236-244.

2.364

17

Validation of a method for recording pharmaceutical interventions.

Fernández-Llamazares CM, Manrique-Rodríguez S, Pérez-Sanz C, Durán-García ME, Sanjurjo-Sáez M, Calleja-Hernández MA.

J Clin Pharm Ther. 2012 Aug;37(4):459-63.

2.104

18

Investigar y publicar en Atención Farmacéutica: una labor por fortalecer.

Amariles P, Sabater-Hernández D, Faus MJ.

Vitae. 2012; 19(1): 9-11.

0.325

19

Validation of a Methodology for Inpatient Pharmacotherapy follow-up.

Becerra J, Martínez F, Bohorquez M, L. Guevara M, Ramirez N E.

Vitae, 2012; 19, 3: 261-269.

0.325

20

Adecuación de la profilaxis antimicrobiana perioperatoria en apendicitis.

Colmenares ME, Labastida C, Aznarte Padial P, Calleja Hernández MA, Martínez Martínez F.

Aten Farm 2012; 14(4): 245-250.

0.125

21

Estudio piloto sobre el manejo de la fluidoterapia intravenosa en pacientes adultos de un hospital de tercer nivel.

Cordero Cruz AM, Moreno Villares JM, Gomis Muñoz P, Valero Zanuy MA, Calleja Hernández MA.

Nutr Hosp. 2012; 27(3): 943-947.

1.305

22

Intensive Two-Month Intervention on Diet and Lifestyle in Uncontrolled Hypertensive Patients in a Community Pharmacy.

Zaragoza-Fernández MP, Gastelurrutia MA, Cardero M, Martínez-Martínez M.

Lat Am J Pharm. 2012; 31 (5): 727-733.

0.244

23

Pharmaceutical care for patients undergoing assisted reproduction techniques. European Journal of Hospital Pharmacy.

Heredia M, Tenías JM, Ruiz R, Sánchez M, CallejaMA, Martínez F.

Eur J Hosp Pharm 2012; 19: 289-292.

0.433

2011

1

Controversies in the management of adjuvant breast cancer with taxanes: review of the current literature

Araque Arroyo P, Ubago Pérez R, Cancela Díez B, Fernández Feijóo MA, Hernández Magdalena J, Calleja Hernández MA.

Cancer Treat Rev. 2011 Apr; 37(2): 105-110

6.024

2

Obesity paradox and risk of sudden death in heart failure

Gastelurrutia P, Pascual-Figal D, Vazquez R, Cygankiewicz I, Grigorian-Shamagian L, Puig T, el al.

Am Heart J. 2011; 161(1): 158-164

4.651

3

Magnitude of the white-coat effect in the community pharmacy setting. The MEPAFAR study

Sabater-Hernández D, de la Sierra A, Sánchez-Villegas P, Baena MI, Amariles P, Faus MJ.

Am J Hypertens. 2011; 24(8): 887-892

3.181

4

Agreement between community pharmacy physicians office and home blood pressure measurement methods. The Palmera study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Am J Hypertens. 2011; 25(3): 290-296

3.181

5

Relationship between kidney damage and blood pressure measurements in the community pharmacy, at home and the physicians office. The Palmera study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Am J Hypertens. 2011; 29 (e-Suppl.A): e-313

3.181

6

Negative clinical outcomes associated with drug-related problems in heart failure (HF) out patiens: impact of a pharmacist in a multidisciplinary HF clinic

Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues A, Bayes-Genis A.

J Card Fail. 2011; 17(3): 217-223

3.660

7

Effect of pharmacist involvement in adherence to medications in patients with high to moderate cardiovascular risk (Study EMDADER-CV-INCUMPLIMIENTO)

Rodríguez Chamorro MA, García-Jiménez E, Amariles P, Chamorro AR, Merino EM, Martínez FM, Dader MJ.

Aten Primaria. 2011 May; 43(5): 245-253

0.627

8

Evaluation of the hypertensive state in treated patients: selection of appropriate blood pressure measurements per visit to community pharmacy

Sabater-Hernández D, Sánchez-Villegas P, Lacampa P, Artiles-Campelo A, Jorge-Rodriguez ME, Faus MJ.

Blood Press Monit. 2011; 16(3): 103-110.

1.520

9

Comparison of the white-coat effect in the community pharmacy versus the physian office. The PALMERA study

Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortola A, Martínez-Martínez F.

Blood Press Monit. 2011; 16(2): 62-66

1.520

10

Analysis of the effects of pharmacotherapeutic follow-up in hypothyroid patients seen in community pharmacy

Bofí Martínez P, García-Jiménez E, Martínez- Martínez F.

Aten Primaria. 2011 Jan; 43(1):50-52

0.627

11

Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)

Rodríguez Chamorro MÁ, García-Jiménez E, Amariles P, Rodríguez Chamorro A, Pérez Merino E, Martínez Martínez F y Faus Dader MJ.

Aten Primaria. 2011; 43(5): 245-253

0.627

12

Investigación en Atención Farmacéutica: una necesidad con ciertos requisitos

Amariles P, Faus MJ.

Aten Farm. 2011; 13(1): 3-5

0.082

13

Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study

Sabater-Hernández D, Sánchez-Villegas P, Amariles P, García-Corpas JP, Sendra-Lillo J, Faus MJ.

Int J Clin Pharm. 2011; 33(3): 582-589.

0.859

14

Bioelectrical impedance vector analysis (BIVA) in stable and non-stable heart failure patients: a pilot study

Gastelurrutia P, Nescolarde L, Rosell-Ferrer J, Domingo M, Ribas N, Bayes-Genis A.

Int J Cardiol. 2011; 146(2): 262-264

1.185

15

Control de errores por alergias cruzadas a antibióticos betalactámicos

Sánchez IM, Nájera MD, Calleja MA, Belchi J.

Aten Farm 2011; 13(2): 121-123

0.082